TP53 and ovarian cancer: Not surprisingly, the earliest publications on breast and ovarian cancers in African populations focused on understanding the contribution of variations in the tumor suppressor genes BRCA1/2 and TP53, particularly in North African populations of Morocco, Tunisia, Egypt, and Sudan (26–40).